$OPGN News Article - ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany: Today's Top Stories | Benzinga
https://marketwirenews.com/news-releases/chat...20687.html